From the Thibierge-Weissenbach syndrome (1910) (or CRST syndrome) to anticentromere antibodies (1980). Clinical and biological manifestations of progressive systemic sclerosis;Du syndrome de Thibierge-Weissenbach (1910) aux anticorps anti- centromere (1980). De la clinique a la biologie des sclerodermies

Annales de Medecine Interne

Volumn 150, Issue 1, 1999, Pages 47-52

  Meyer, Olivier ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Anti RNA polymerase III ab; Anti Scl 70 ab.; Anticentromere ab.; CREST syndrome; Cutaneous calcinosis; Progressive systemic sclerosis

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; DNA TOPOISOMERASE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; HUMAN; PROGNOSIS; RAYNAUD PHENOMENON; SCLERODERMA; SKIN CALCIFICATION; SYNDROME CREST; SYSTEMIC SCLEROSIS; TELANGIECTASIA;

ANTIBODIES, ANTINUCLEAR; CENTROMERE; CREST SYNDROME; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS;

EID: 0032913189     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. er Juillet 1910, p. 10-15.
2. WINTERBAUER RH : Multiple telangiectasies, Raynaud's phenomenon, sclerodactyly and subcutaneous calcinosis: a syndrome mimicking hemorrhagic telangiectasia. Bull John Hopkins Hosp, 1964 ; 114 : 361-83.
3. RODNAN GP, BENEDEK TG : An historical account of the study of progressive systemic sclerosis. Ann Intern Med, 1962 ; 57 : 305-318.
4. MEYER O : Clinical, serological and immunogenetic studies of systemic sclerosis : réponse française à la communication du Professeur PJ Maddison. Rev Rhum, 1991 ; 58 : 371-3.
5. BARNETT AJ : History of scleroderma. In: PJ Clements, De Furst edit. Systemic sclerosis. Baltimore : Williams and Wilkins, 1996 : 1-22.
6. MEDSGER TA Jr : Classification of systemic sclerosis. In: Jayson MIV, Black CM edit. Systemic sclerosis : scleroderma John Wiley & Sons, 1988 : 1-6.
7. BARNETT AJ : Classification and course problems in classification. In: Scleroderma. Springfield, Illinois, USA : Charles C Thomas, 1974 : 71-93.
8. GIORDANO M, ARA M, CAPELLI L, TIRI G, VATTI M : Vorschlag zu einer neuen Klassifizierung und Nomenklatur des progredienten generalisierten Sklerodermie (PGS). Verh Disch Ges Rheumatol, 1980 ; 6 : 379-82.
9. RODNAN GP, JABLONSKA S, MEDSGER TA Jr : Classification and nomenclature of progressive systemic sclerosis (scleroderma). Clin Rheum Dis, 1979 ; 5 : 5-13.
10. TUFFANELLI DL, WINKELMANN RK : Diffuse systemic scleroderma : a comparison with acrosclerosis. Ann Intern Med, 1962 ; 57 : 198-203.
11. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification os systemic sclerosis (scleroderma). Arthritis Rheum, 1980 ; 23 : 581-90.
12. BARNETT AJ, COVENTRY DA : Scleroderma : clinical features, cause of illness and responses to treatment in 61 cases. Med J Aust, 1969 ; 1 : 992-1001.
13. PARENT-WOILLEZ K, HACHULLA E, BAUTERS C, HATRON PY, BROUILLARD M, RIFAI A, DEVULDER B : L'hypertension artérielle pulmonaire primitive : une complication rare mais souvent mortelle du Crest syndrome. Rev Méd Interne, 1997 ; 18 : 109-13.
14. STUPI AM, STEEN VD, OWENS GR, BARNES EL, RODNAN GP, MEDSGER TA Jr : Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum, 1986 ; 29 : 515-24.
15. MOROI Y, PEEBLES C, FRITZLER J, STEIGERWALD J, TAN EM : Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA, 1980 ; 77 : 1627-31.
16. DOUVAS AS, ACHTER M, TAN EM : Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem, 1979 ; 254 : 10514-22.
17. KUWANA M, KABURAKI J, MIMORI T, TOJO T, HOMMA M : Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest, 1993 ; 91 : 1399-404.
18. OKANO Y, STEEN VD, MEDSGER TA Jr : Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med, 1993 ; 119 : 1005-13.
19. BECK JS, ANDERSON JR, GRAY KG, ROWELL NR : Antinuclear and precipitating autoantibodies in progressive systemic sclerosis. Lancet, 1963 ; 11 : 1188-90.
20. JORDON RE, DEHEER D, SCHROETER A, WINKELMANN RK : Antinuclear antibodies : their significance in scleroderma. Mayo Clin Proc, 1971 ; 46 : 111-13.
21. ROTHFIELD NF, RODNAN GP : Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum, 1968 ; 11 : 607-17.
22. EARNSHAW W, BORDWELL B, MARINO C, ROTHFIELD N : Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest, 1986 ; 77 : 426-30.
23. FRITZLER MJ, VALENCIA DW, MCCARTY GA : Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum, 1984 ; 27 : 92-6.
24. VERHEIJEN R, DE JONG BAW, VAN VENROOIJ WJ : A recombinant topoisomerase I ELISA : screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera. Clin Exp Immunol, 1992 ; 89 : 456-60.
25. VAZQUEZ-ABAD D, WALLACE S, SENECAL JL, JOYAL F, ROUSSIN A, EARNSHAW WC, ROTHFIELD N : Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen. Arthritis Rheum, 1994 ; 37 : 248-52.
26. SUN D, MARTINEZ A, SULLIVAN KF, SHARP GC, HOCH SO : Detection of anticentromere antibodies using recombinant human CENP-A protein. Arthritis Rheum, 1996 ; 39 : 963-67.
27. MCCARTY GA, RICE JR, BEMBE ML, BARADA FA Jr : Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum, 1983 ; 26 : 1-7.
28. MEYER O, HAIM T : Les anticorps anticentromère. Valeur diagnostique et pronostique. Presse Méd, 1982 ; 11 : 2891-4.
29. STEEN VD, ZIEGLER GL, RODNAN GP, MEDSGER TA Jr : Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum, 1984 ; 27 : 125-31.
30. AESCHLIMANN A, MEYER O, BOURGEOIS P, HAÏM T, BELMATOUG N, PALAZZO E, KAHN MF : Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis : specificity and clinical correlations. Ann Rheum Dis, 1989 ; 48 : 992-7.
31. FERRI C, BERNINI L, CECCHETTI R, LATORACA A, MAROTTA G, PASERO G, NERI R, BOMBARDIERI S : Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol. 1991 ; 18 : 1826-32.
32. MEYER O. How useful are serum autoantibodies in the diagnosis and prognosis of systemic sclerosis ? Clin Reumatol, 1998 ; 17 : 179-80.
33. REIMER G : Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma). Rheum Dis North America, 1990 ; 16 : 169-83.
34. TAN EM, RODNAN GP, GARCIA I, MOROI Y, FRITZLER MJ, PEEBLES C : Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum, 1980 ; 23 : 617-25.
35. WEINER ES, EARNSHAW WC, SENECAL JL, BORDWELL B, JOHNSON P, ROTHFIELD NF : Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum, 1988 ; 31 : 378-85.
36. SPENCER-GREEN G, ALTER D, WELCH HG : Test performance in systemic sclerosis : anti-centromere and anti-Scl70 antibodies. Amer J Med, 1997 ; 103 : 242-48.
37. RUFFATTI A, CALLIGARO A, FERRI C, BOMBARDIERI S, GAMBARI PF, TODESCO S : Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases. J Clin Lab Immunol, 1985 ; 16 : 227-9.
38. TUBACH F, HAYEM G, ELIAS A, NICAISE P, HAIM T, KAHN MF, MEYER O : Les anticorps anticentromère en pratique rhumatologique ne sont pas toujours associés à une sclérodermie. Rev Rhum, 1997 ; 64 : 363-8.
39. OKANO Y : Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North America, 1996 ; 22 : 709-35.
40. KUWANA M, KABURAKI J, OKANO Y, TOJO T, HOMMA M : Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthrtis Rheum, 1994 ; 37 : 75-83.
41. JACOBSEN S, HALBERG P, ULLMAN S, VAN VENROOIJ WJ, HOIER-MADSEN M, WIIK A, PETERSEN J : Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Brit J Rheumatol, 1998 ; 37 : 39-45.
42. BERNSTEIN RM, STEIGERWALD JC, TAN EM : Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol, 1982 ; 48 : 43-51.
43. ARNETT FC, REVEILLE JD, GOLDSTEIN R, POLLARD KM, LEAIRD K, SMITH EA, LEROY EC, FRITZLER MJ : Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum, 1996 ; 39 : 1151-60.
44. OKANO Y, STEEN VD, MEDSGER TA Jr : Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum, 1992 ; 35 : 95-100.
45. FALKNER D, WILSON J, MEDSGER TA Jr, MOREL PA : HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies. Arthritis Rheum, 1998 ; 41 : 74-80.
46. MARGUERIE C, BUNN CC, COPIER J, BERNSTEIN RM, GILROY JM, BLACK CM, SO AK, WALPORT MJ : The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine, 1992 ; 71 : 327-36.
47. RODRIGUEZ-SANCHEZ JL, GELPI C, JUAREZ C, HARDIN JA : Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90 kDa component of the nucleolus organizing region of chromatin 1. J Immunol, 1987 ; 139 : 2579-84.
48. BUNN CC, DENTON CP, SHI-WEN X, KNIGHT C, BLACK CM : Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Brit J Rheumatol, 1998 ; 37 : 15-20.
49. REIMER G, ROSE KM, SCHEER U, TAN EM : Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest, 1987 ; 79 : 65-72.
50. KUWANA M, OKANO Y, KABURAKI J, TOJO T, MEDSGER TA Jr : Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum, 1994 ; 37 : 902-6.
51. MCNEILAGE LJ, YOUNGCHAIYUD U, WHITTINGHAM S : Racial difference in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum, 1989 ; 32 : 54-60.
52. HIETARINTA M, MEYER O, HAIM T, ELIAS A, KAHN MF : Antinuclear and antinucleolar antibodies in patients with scleroderma-polymyositis overlap syndrome. Brit J Rheumatol, 1996 ; 35 : 1326-7.
53. SARKOZI J, BOOKMAN AAM, LEE P, KEYSTONE EC, FRITZLER MJ : Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Amer J Med, 1987 ; 83 : 893-8.
54. TRAMPOSCH HD, SMITH CD, SENEGAL JL, ROTHFIELD N : A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum, 1984 ; 27 : 121-4.
55. VAZQUEZ-ABAD D, RUSSELL CA, CUSICK SM, EARNSHAW W, ROTHFIELD NF : Longitudinal study of anticentromere and antitopoisomerase-I isotypes. Clin Immunol Immunopathol, 1995 ; 74 : 257-70.
56. REIMER G, STEEN VD, PENNING CA, MEDSGER TA Jr, TAN EM : Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum, 1988 ; 31 : 525-32.
57. HARVEY G, BLACK C, MADDISON P, MCHUGH N : Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. J Rheumatol, 1997 ; 24 : 477-84.